High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: A cross-sectional study in two hospitals in northern Uganda

BMJ Open

Volumn 4, Issue 11, 2014, Pages

  Bayo, Pontius ^a   Ochola, Emmanuel ^a,b   Oleo, Caroline ^b,c   Mwaka, Amos Deogratius ^c  

^a St Mary's Hospital Lacor Uganda   (Uganda)

^b GULU UNIVERSITY   (Uganda)

^c MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LIVER ENZYME;

ADOLESCENT; ADULT; ARTICLE; BIRTH; COHABITING PERSON; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PREGNANT WOMAN; PRENATAL CARE; SCAR FORMATION; SEXUALITY; TERTIARY CARE CENTER; UGANDA; VACCINATION; CLINICAL TRIAL; HEPATITIS B, CHRONIC; MULTICENTER STUDY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; YOUNG ADULT;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PREVALENCE; TERTIARY CARE CENTERS; UGANDA; YOUNG ADULT;

EID: 84911998115     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005889     Document Type: Article

References (28)

1. Ching-Lung L, Man-Fung Y. Chronic hepatitis B-new goals, new treatment. N Engl J Med 2008;359:2488-91.
2. Ott JJ, Stevens GA, Wiersma ST. The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions. BMC Infect Dis 2012;12:131.
3. Stevens CE, Toy PT, Tong MJ, et al. Hepatitis B virus transmission in the United States, prevention by passive-active immunization. JAMA 1985;253:1740-5.
4. Tassopoulos NC, Papaevangelou GJ, Sjorgen MH, et al. Natural history of acute hepatitis B surface antigen positive hepatitis in Greek adults. Gastroenterology 1987;92:1844-50.
5. Beasley PR. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma, epidemiologic considerations. Hepatology 1982; (Suppl):21S-6S.
6. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 2003;(Suppl 1):S64-9.
7. WHO. Introduction of hepatitis B vaccine into childhood immunization services: management guidelines, including information for health workers and parents. Department of Vaccines and Biologicals. Geneva: World Health Organisation, 2001.
8. US Preventive Services Task Force. Screening for hepatitis B virus infection in pregnancy: U.S Preventive Task Force Reaffirmation Recommendation Statement. Ann Intern Med 2009;150:869-73.
9. Ministry of Health Republic of Uganda. Annual Health Sector Performance Report 2007-2008. In: Health, editor: MoH, 2008.
10. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97-107.
11. Andre FE, Zuckerman AJ. Protective efficacy of hepatitis B vaccines in neonates. J Viral Hepat 1994;44:144-1.
12. Mbaawuaga EM, Enenebeaku MNO, Okopi JA, et al. Hepatitis B virus (HBV) infection among pregnant women in Makurdi, Nigeria. Afr J Biomed Res 2008;11:155-9.
13. Rujumba J, Kwiringira J. Interface of culture, insecurity and HIV and AIDS: lessons from displaced communities in Pader District, Northern Uganda. Confl Health 2010 4:18.
14. Ministry of Health Uganda. Uganda HIV/AIDS Sero-behavioural Survey 2004-2005. Calverton Maryland, USA: Uganda Ministry of Health and ORC Macro, 2006:125-32.
15. Ochola E, Ocama P, Orach CG, et al. High burden of hepatitis B infection in Northern Uganda: results of a population-based survey. BMC Public Health 2013;13:727.
16. St. Mary's Hospital Lacor. Lacor Hospital Annual Report Financial Year 2012/2013. Gulu: Lacor Hospital, 2013.
17. Råssjö EB, Mirembe F Darj E. Self reported sexual behaviour among adolescent girls in Uganda: reliability of data debated. Afr Health Sci 2011;11:383-9.
18. WHO. Preventing mother-to-child transmission of hepatitis B : operational field guidelines for delivery of the birth dose of hepatitis B vaccine. Manilla: WHO, 2006.
19. Sorrel MF, Belongia EA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B. Ann Intern Med 2009;150:104-10.
20. Pirillo MF, Bassani L, Elena AP, et al. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda. J Med Virol 2007;79:1797-801.
21. Stabinkski L, Reynolds SJ, Ocama P, et al. Hepatitis B virus and sexual behaviour in Rakai, Uganda. J Med Virol 2012;83:796-800.
22. Bwogi J, Braka F, Makumbi I, et al. Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. Afr Health Sci 2009;9:98-108.
23. Mansour W, Malick F-ZF, Sidiya A, et al. Risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J Med Virol 2012;84 (April):1186-98.
24. Ministry of Health Uganda. Uganda AIDS Indicator Survey 2011. MoH, 2012.
25. Giles ML, Visvanathan K, Lewin SR, et al. Chronic hepatitis B infection and pregnancy. Obstet Gynecol Surv 2012;67:37-44.
26. Dwivedi M, Misra SP, Mishra V, et al. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol 2011;30:66-71.
27. Phillippe R, Alassane D, Chiekh B, et al. Perinatal transmission of hepatitis B virus in Senegal, West Africa. J Viral Immunol 1993;6:65-73.
28. Khamduang W, Ngo-giang-huong N, Gaudy-graffin C, et al. Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. Clin Infect Dis 2013:1-9.